Malignant Melanoma of Skin: Clinical Trials

3 trials for Malignant Melanoma of Skin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 31Recruiting 1

Follow Malignant Melanoma of Skin: new trials by email Literature Review of Malignant Melanoma of Skin trials Research Report on Malignant Melanoma of Skin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis
Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin
Phase 3RecruitingMemorial Sloan Kettering Cancer Center140002026-10-152026-10-22
Intratumoral PH-762 for Cutaneous Carcinoma
PH-762 - Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin
Phase 1CompletedPhio Pharmaceuticals Inc.222023-11-072026-09-21
Employment and Quality of Life in Patients With Malignant Melanoma
Quality of Life, status of employment - Malignant Melanoma of Skin, Quality of Life
CompletedFachklinik Hornheide an der Universität Münster2212016-04-012019-02-15

Narrower conditions

Melanoma (3)  ·  Hemangioma (1)  ·  Keratosis, Seborrheic (1)  ·  Nevus (1)  ·  Nevus, Pigmented (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms by Site (3)  ·  Neoplasms, Germ Cell and Embryonal (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neuroectodermal Tumors (3)  ·  Neuroendocrine Tumors (3)  ·  Nevi and Melanomas (3)  ·  Skin Diseases (3)  ·  Skin Neoplasms (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Keratosis (1)  ·  Neoplasms, Vascular Tissue (1)

Interventions

Quality of Life (1)

Sponsors

Fachklinik Hornheide an der Universität Münster (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  Phio Pharmaceuticals Inc. (1)

Countries

United States (2)  ·  Germany (1)

Top investigators

Hans-Joachim Schulze, M.D. (1)  ·  Linda Mahoney (1)  ·  Veronica Rotemberg, MD (1)

Results publications

PMID 39697325

NIH funding

R01CA293974 (1)